NDRA — ENDRA Life Sciences Share News
0.000.00%
Last trade - 00:00Brief: Endra Life Sciences Got Letter From Nasdaq On No Longer Meeting Continued Listing Minimum Bid Price Requirement
Brief: ENDRA Life Sciences Issues Five New International Patents
Brief: Endra Life Sciences Files For Public Offering Of Shares Of Common Stock
Brief: Endra Life Sciences Entered Into An At-The-Market Issuance Sales Agreement Relating To Offer And Sale Of Up To $6.2 Million Of Our Common Stock
U.S. STOCKS ON THE MOVE-Gold miners, Spirit Airlines, AT&T
Endra Life Sciences Inc Reports Results For The Quarter Ended In December: Earnings Summary
Endra Life Sciences Inc Expected To Post A Loss Of 36 Cents A Share: Earnings Preview
Endra Life Sciences Inc Expected To Post A Loss Of 36 Cents A Share: Earnings Preview
Brief: Endra Life Sciences Files For Mixed Shelf Offering Of Up To $50 Million - SEC Filing
U.S. RESEARCH ROUNDUP-Boot Barn Holdings, Hershey Co, Ulta Beauty
Brief: ENDRA Life Sciences Bags Three New Patents
Brief: Endra Life Sciences' Taeus De Novo Submission Advances To Next Stage Of Review With FDA
U.S. RESEARCH ROUNDUP-Intuit, Pioneer Natural Resources, Salesforce
Brief: Endra Life Sciences Expands Intellectual Property With Issuance Of U.S. And European Patents
Endra Life Sciences Inc Reports Results For The Quarter Ended In June: Earnings Summary
Brief: Endra Life Sciences Submits De Novo Request For Its Taeus System Liver Fat Application To FDA
Endra Life Sciences Inc Expected To Post A Loss Of 55 Cents A Share: Earnings Preview
Endra Life Sciences Inc Reports Results For The Quarter Ended In March: Earnings Summary
Brief: ENDRA Life Sciences Reports First Quarter 2023 Financial Results